Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA; BLISS-52 Study Group. Navarra SV, et al. Among authors: lan jl. Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4. Lancet. 2011. PMID: 21296403 Clinical Trial.
Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).
Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G, Collinson N, Shaw TM; MIRROR Trial Investigators. Rubbert-Roth A, et al. Rheumatology (Oxford). 2010 Sep;49(9):1683-93. doi: 10.1093/rheumatology/keq116. Epub 2010 May 12. Rheumatology (Oxford). 2010. PMID: 20463186 Free PMC article. Clinical Trial.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women.
BonAdASIA Study Group; Kung AW, Rachman IA, Adam JM, Roeshadi D, Torralba T, Navarra S, Gamilla Z, Cañete A, de la Rosa M, Tsai K, Lin HY, Soong YK, Lan JL, Hsu HC, Tu ST, Lin RM, Yuktanandana P, Songpatanasilp T, Ngarmukos S, Soontrapa S, Soontrapa S, Rojanasthien S, Luevitoonvechkij S, Leerapan T, Albert A, Vanbelle S. BonAdASIA Study Group, et al. Among authors: lan jl. Int J Rheum Dis. 2009 Sep;12(3):216-24. doi: 10.1111/j.1756-185X.2009.01413.x. Int J Rheum Dis. 2009. PMID: 20374349 Clinical Trial.
Carrier-phonon decoupling in perovskite thermoelectrics via entropy engineering.
Zheng Y, Zhang Q, Shi C, Zhou Z, Lu Y, Han J, Chen H, Ma Y, Zhang Y, Lin C, Xu W, Ma W, Li Q, Yang Y, Wei B, Yang B, Zou M, Zhang W, Liu C, Dou L, Yang D, Lan JL, Yi D, Zhang X, Gu L, Nan CW, Lin YH. Zheng Y, et al. Among authors: lan jl. Nat Commun. 2024 Sep 3;15(1):7650. doi: 10.1038/s41467-024-52063-5. Nat Commun. 2024. PMID: 39223124 Free PMC article.
256 results